ADAM17 and rheumatoid arthritis: Increased tissue ADAM17 expression has been reported in different immune-mediated inflammatory diseases, including rheumatoid arthritis, psoriasis and inflammatory bowel disease highlighting its role in mediating downstream injury/inflammation (6–8).